Monte Rosa Therapeutics Reports Pricing Of $100M Public Offering
The company announced the pricing of an underwritten public offering of 10.638 million shares of its common stock at a public offering price of $4.70 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 10.638 million shares of common stock at a public offering price of $4.6999 per pre-funded warrant, which represents the per share public offering price of each share of common stock less the $0.0001 per share exercise price for each pre-funded warrant.